Pulmonx Corp
NASDAQ:LUNG
Pulmonx Corp
NASDAQ:LUNG
Price:
7.53 USD
-5.99%
Market Closed
Updated:
May 30, 2024
Pulmonx Corp
Accrued Liabilities
|
Pulmonx Corp
Accrued Liabilities Peer Comparison
Comparables:
COO
XRAY
ALGN
LNTH
Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Pulmonx Corp
NASDAQ:LUNG
|
Accrued Liabilities
$18.8m
|
CAGR 3-Years
25%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
|
Cooper Companies Inc
NYSE:COO
|
Accrued Liabilities
$178.7m
|
CAGR 3-Years
7%
|
CAGR 5-Years
19%
|
CAGR 10-Years
14%
|
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Accrued Liabilities
$590m
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
6%
|
|
|
Align Technology Inc
NASDAQ:ALGN
|
Accrued Liabilities
$496.6m
|
CAGR 3-Years
11%
|
CAGR 5-Years
15%
|
CAGR 10-Years
21%
|
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Accrued Liabilities
$146.2m
|
CAGR 3-Years
61%
|
CAGR 5-Years
43%
|
CAGR 10-Years
17%
|
See Also
What is Pulmonx Corp's Accrued Liabilities?
Accrued Liabilities
18.8m
USD
18.8m
USD
Based on the financial report for Dec 31, 2023, Pulmonx Corp's Accrued Liabilities amounts to 18.8m USD.
What is Pulmonx Corp's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
28%
28%
Over the last year, the Accrued Liabilities growth was 18%. The average annual Accrued Liabilities growth rates for Pulmonx Corp have been 25% over the past three years , 28% over the past five years .
You don't have any saved screeners yet
